# Medical Management of Sleep Disturbance During Opioid Tapering

> **NCT03789214** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 90 (actual)

## Conditions studied

- Opioid Dependence
- Opioid Withdrawal
- Sleep Disturbance

## Interventions

- **DRUG:** Placebo oral capsule
- **DRUG:** Low Dose Suvorexant
- **DRUG:** High Dose Suvorexant

## Key facts

- **NCT ID:** NCT03789214
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2021-06-10
- **Final completion:** 2021-06-10
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03789214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03789214, "Medical Management of Sleep Disturbance During Opioid Tapering". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03789214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*